NCT07571707 Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General Anesthesia
| NCT ID | NCT07571707 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Udayana University |
| Condition | Emergence Agitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2026-04-10 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effectiveness of lollipop administration after surgery in reducing emergence agitation in pediatric patients undergoing anesthesia with sevoflurane at RS Ngoerah. Emergence agitation is a common condition in children after general anesthesia, characterized by restlessness, confusion, and distress during recovery. This study investigates whether providing a lollipop as a simple, non-pharmacological intervention can help reduce the incidence and severity of agitation. Pediatric patients undergoing surgery with sevoflurane anesthesia will be observed postoperatively, and their level of agitation will be assessed using standardized evaluation methods. The results of this study are expected to provide a safe, practical, and easily applicable approach to improve postoperative recovery in children.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients aged 2-6 years * Scheduled for elective surgery under general anesthesia with sevoflurane * American Society of Anesthesiologists (ASA) physical status I-II * Written informed consent obtained from parents or legal guardians Exclusion Criteria: * Known allergy or contraindication to study-related procedures * Developmental delay or neurological disorders affecting behavior assessment * Use of sedative or psychoactive medications prior to surgery * History of emergence delirium or significant behavioral disorders * Intraoperative complications requiring deviation from standard anesthesia protocol
Contact & Investigator
I Putu Kurniyanta, MD, PhD, Sp.An
PRINCIPAL INVESTIGATOR
Udayana University, Denpasar, Indonesia
Frequently Asked Questions
Who can join the NCT07571707 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 6 Years, studying Emergence Agitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07571707 currently recruiting?
Yes, NCT07571707 is actively recruiting participants. Contact the research team at antasari.2271101003@student.unud.ac.id for enrollment information.
Where is the NCT07571707 trial being conducted?
This trial is being conducted at Denpasar, Indonesia.
Who is sponsoring the NCT07571707 clinical trial?
NCT07571707 is sponsored by Udayana University. The principal investigator is I Putu Kurniyanta, MD, PhD, Sp.An at Udayana University, Denpasar, Indonesia. The trial plans to enroll 66 participants.